These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24377631)

  • 21. hTERT gene expression levels and telomerase activity in drug resistant MCF-7 cells.
    Sakin V; Eskiocak U; Kars MD; Iseri OD; Gunduz U
    Exp Oncol; 2008 Sep; 30(3):202-5. PubMed ID: 18806742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase.
    Mollazade M; Nejati-Koshki K; Akbarzadeh A; Zarghami N; Nasiri M; Jahanban-Esfahlan R; Alibakhshi A
    Asian Pac J Cancer Prev; 2013; 14(11):6925-8. PubMed ID: 24377627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
    Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
    Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
    Loo WT; Chen JP; Chow LW; Chou JW
    Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water-Soluble Ruthenium(II) Complexes with Chiral 4-(2,3-Dihydroxypropyl)-formamide Oxoaporphine (FOA): In Vitro and in Vivo Anticancer Activity by Stabilization of G-Quadruplex DNA, Inhibition of Telomerase Activity, and Induction of Tumor Cell Apoptosis.
    Chen ZF; Qin QP; Qin JL; Zhou J; Li YL; Li N; Liu YC; Liang H
    J Med Chem; 2015 Jun; 58(11):4771-89. PubMed ID: 25988535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone.
    Kim SH; Oh SM; Kim TS
    Eur J Pharmacol; 2005 Mar; 511(2-3):89-97. PubMed ID: 15792776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-dependent cytotoxic effects of boldine in HepG-2 cells-telomerase inhibition and apoptosis induction.
    Noureini SK; Wink M
    Molecules; 2015 Feb; 20(3):3730-43. PubMed ID: 25719742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxypropyl-β-Cyclodextrin and β-Cyclodextrin as Tablet Fillers for Direct Compression.
    Conceição J; Adeoye O; Cabral-Marques HM; Sousa Lobo JM
    AAPS PharmSciTech; 2018 Aug; 19(6):2710-2718. PubMed ID: 29978292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
    Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro.
    Lanzilli G; Fuggetta MP; Tricarico M; Cottarelli A; Serafino A; Falchetti R; Ravagnan G; Turriziani M; Adamo R; Franzese O; Bonmassar E
    Int J Oncol; 2006 Mar; 28(3):641-8. PubMed ID: 16465368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin.
    Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W
    Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
    Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
    Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of vinorelbine on apoptosis and expression of telomerase activity in human lung adenocarcinoma cells in vitro].
    Liu JJ; Chen GY; Wang M; Yang ZY; Hong X
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):743-7. PubMed ID: 21163063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
    Baek JS; Cho CW
    J Pharm Pharmacol; 2013 Jan; 65(1):72-8. PubMed ID: 23215690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation.
    Noureini SK; Wink M
    Asian Pac J Cancer Prev; 2012; 13(5):2305-9. PubMed ID: 22901211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Patents on Anti-Cancer Potential of Helenalin.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2020; 15(2):132-142. PubMed ID: 32614752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.